Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomePressVideos & PodcastsVideos
Results 19 to 27 of total 52
The flagella, which is comprised of tens of thousands of flagellin proteins, is not only important for the movement of Salmonella but also plays a key role in its ability to invade the human host cell. The parts of the flagellin proteins that are exposed are highly versatile and subject to modification by enzymes. One such modification, known as methylation, occurs when a methyl…
The majority of patients with severe COVID-19 develop unusually pronounced scarring of the lungs. This was the conclusion of a study conducted by researchers from Charité – Universitätsmedizin Berlin, the Helmholtz Institute for RNA-based Infection Research (HIRI), the Max Delbrück Center for Molecular Medicine (MDC), the RWTH Aachen University Medical Center and the Robert Koch Institute.…
It is estimated that more than 250 million people worldwide are chronically infected with the hepatitis B virus. Cytotoxic T cells and T helper cells play an important role in fighting viral infections. The constant activation of these immune cells in chronically infected patients leads to cell exhaustion in the long term. However, their activability is a prerequisite to…
Personalised infection medicine aims to take into account individual differences in the diagnosis and therapy of infectious diseases. The HZI and McGill University have been building a strategic cooperation on this topic for several years. Clinicians and scientists from the institutions will come together for a symposium on 29 November 2021 to share their perspectives and…
They emphasise that it is important to ensure
that more incentives are provided for research and development on new anti-bacterial drugs, that new antibiotics against problem germs reach patients quickly, that the potential of vaccines to reduce the risk of bacterial infections is fully exploited, and that antibiotics that are still effective today are used even more…